Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000308557 | SCV005061689 | likely benign | Glanzmann thrombasthenia | 2024-02-20 | reviewed by expert panel | curation | The c.2085C>T variant in ITGB3 is a single nucleotide substitution that does not alter the protein sequence (p.Tyr695=). This variant is predicted by SpliceAI to have no significant splicing motif alteration detected (Delta score 0.00) and the nucleotide is not highly conserved (PhyloP score 0.24806) (BP4, BP7). This variant occurs at a very low allele frequency overall in gnomAD v4.0.0 of 0.00004523 with a MAF of 0.00004005 (3/74910) in African/ African American subpopulation (PM2_Supporting). In summary, this variant meets the criteria to be classified as Likely Benign for autosomal recessive Glanzmann Thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: BP7, PM2_Supporting, BP4 |
Illumina Laboratory Services, |
RCV000308557 | SCV000403745 | uncertain significance | Glanzmann thrombasthenia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002522983 | SCV003512991 | likely benign | not provided | 2024-09-21 | criteria provided, single submitter | clinical testing |